Emergence of increased resistance to quinupristin/dalfopristin during therapy for Enterococcus faecium bacteremia

Clin Infect Dis. 1997 Jan;24(1):90-1. doi: 10.1093/clinids/24.1.90.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Bacteremia / drug therapy*
  • Drug Resistance, Microbial
  • Drug Resistance, Multiple
  • Echocardiography
  • Enterococcus faecium*
  • Gram-Positive Bacterial Infections / drug therapy*
  • HIV Infections / complications*
  • HIV Infections / microbiology*
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Vancomycin / pharmacology
  • Virginiamycin / therapeutic use*

Substances

  • Anti-Bacterial Agents
  • Virginiamycin
  • quinupristin-dalfopristin
  • Vancomycin